Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
cabazitaxel angiotensin-

affects exposure

Unknown Theoretical
cabazitaxel antihistamines,non-sedating

affects exposure

Unknown Theoretical
cabazitaxel atorvastatin

affects exposure

Unknown Theoretical
cabazitaxel fexofenadine

affects exposure

Unknown Theoretical
cabazitaxel glibenclamide

affects exposure

Unknown Theoretical
cabazitaxel meglitinides

affects exposure

Unknown Theoretical
cabazitaxel pravastatin

affects exposure

Unknown Theoretical
cabazitaxel repaglinide

affects exposure

Unknown Theoretical
cabazitaxel rosuvastatin

affects exposure

Unknown Theoretical
cabazitaxel simvastatin

affects exposure

Unknown Theoretical
cabazitaxel statins

affects exposure

Unknown Theoretical
cabazitaxel sulfonylureas

affects exposure

Unknown Theoretical
cabozantinib benzodiazepines

increases exposure

Unknown Theoretical
cabozantinib combinedhormonalcontraceptives

affects effects

Unknown Theoretical
cabozantinib midazolam

increases exposure

Unknown Theoretical
caffeinecitrate adenosine

decreases efficacy

Unknown Study
caffeinecitrate antiarrhythmics

decreases efficacy

Unknown Study
calciumchannelblockers afatinib

increases exposure

Unknown Study
calciumchannelblockers apixaban

increases exposure

Unknown Theoretical
calciumchannelblockers berotralstat

increases exposure

Unknown Study
calciumchannelblockers betablockers,non-selective

increases risk of cardiodepression

Unknown Study
calciumchannelblockers betablockers,selective

increases risk of cardiodepression

Unknown Study
calciumchannelblockers darifenacin

increases exposure

Unknown Study
calciumchannelblockers gilteritinib

increases exposure

Unknown Theoretical
calciumchannelblockers larotrectinib

increases exposure

Unknown Theoretical
calciumchannelblockers nintedanib

increases exposure

Unknown Study
calciumchannelblockers pibrentasvir

increases exposure

Unknown Theoretical
calciumchannelblockers relugolix

increases exposure

Unknown Study
calciumchannelblockers topotecan

increases exposure

Unknown Study
calciumchannelblockers trametinib

increases concentration

Unknown Theoretical
calciumchannelblockersarepredictedto increasetheexposuretoneurokinin-1receptorantagonists d andneurokinin-1receptorantagonists calciumchannelblockers

increases exposure

Unknown Study
calciumchannelblockersarepredictedto increasetheexposuretoneurokinin-1receptorantagonists d andneurokinin-1receptorantagonists diltiazem

increases exposure

Unknown Study
calciumchannelblockersarepredictedto increasetheexposuretoneurokinin-1receptorantagonists d andneurokinin-1receptorantagonists verapamil

increases exposure

Unknown Study
calciumchannelblockersincreasetheconcentration ofcarbamazepineandcarbamazepine verapamil

decreases exposure

Unknown Anecdotal
cannabidiol antiepileptics

increases risk of increasedaltconcentrations

Unknown Study
capecitabine antiepileptics

increases concentration

Unknown Anecdotal
capecitabine fosphenytoin

increases concentration

Unknown Anecdotal
capecitabine phenytoin

increases concentration

Unknown Anecdotal
carbamazepine afatinib

decreases exposure

Unknown Study
carbamazepine aliskiren

decreases exposure

Unknown Study
carbamazepine brentuximabvedotin

decreases effects

Unknown Theoretical
carbamazepine dolutegravir

decreases exposure

Unknown Study
carbamazepine methylphenidate

decreases concentration

Unknown Anecdotal
carbamazepine monoclonalantibodies

decreases effects

Unknown Theoretical
carbamazepine nintedanib

decreases exposure

Unknown Study
carbamazepine oralcladribine

increases risk of haematologicaltoxicity

Unknown Theoretical
carbamazepine raltegravir

affects exposure

Unknown Theoretical
carbamazepine suxamethonium

increases risk of prolongedneuromuscularblockade

Unknown Study
carbamazepine tigecycline

decreases exposure

Unknown Theoretical
carbamazepine vitamin

decreases effects

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.